SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                         Commission File Number 0-28498

(Check one)

|_| Form 10-K and Form 10-KSB   |_| Form 11-K

|_| Form 20-F  |X| Form 10-Q and Form 10-QSB  |_| Form N-SAR

For period ended: June 30, 2003

|_| Transition Report on Form 10-K and Form 10-KSB

|_| Transition Report on Form 20-F

|_| Transition Report on Form 11-K

|_| Transition Report on Form 10-Q and Form 10-QSB

|_| Transition Report on Form N-SAR

For the transition period ended _____________________________________________

Read Attached Instruction Sheet Before Preparing Form.  Please Print or Type.

   Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

   If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification
relates_____________________________________________________________________



                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant: Paradigm Medical Industries, Inc.

Former name if applicable: ____________________________________________________

Address of principal executive office (Street and number):

                           2355 South 1070 West
                           Salt Lake City, Utah 84119

                                     PART II
                             RULE 12b-25(b) AND (c)


   If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 132b-25(b), the
following should be completed. (Check box if appropriate).







         (a)      The reasons described in reasonable detail in Part III of this
                  form could not be eliminated without unreasonable effort or
                  expense.
   |X|   (b)      The subject annual report, semi-annual report, transition
                  report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion
                  thereof, will be filed on or before the fifteenth calendar day
                  following the prescribed due date; or the subject quarterly
                  report of transition report on Form 10-Q, or portion thereof
                  will be filed on or before the fifth calendar day following
                  the prescribed due date; and
         (c)      The  accountant's  statement or other exhibit required by Rule
                  12(b)-25(c) has been attached if applicable.

                                    PART III

                                    NARRATIVE

         State below in reasonable detail the reasons why Forms 10-K, 11-K,
10-Q, N-SAR or the transition report or portion thereof, could not be filed
within the prescribed time period. (Attach extra sheets if needed.)

         The Form 10-QSB cannot be completed within the required time period
primarily due to changes in personnel in the Company's accounting department,
including the appointment of Gregory C. Hill as vice president of finance and
chief financial officer of the Company on June 3, 2003, replacing Heber C.
Maughan, who resigned as vice president of finance and chief financial officer
of the Company.




                                     PART IV
                                OTHER INFORMATION


(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
     notification

        Randall A. Mackey                (801)               575-5000
       -----(name)-------------------(area code)-----(telephone number)--------

(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months (or for such shorter) period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s).

         |X|Yes    |_| No

(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

         |_|Yes    |X| No

If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.


                        Paradigm Medical Industries, Inc.
               ---------------------------------------------------
                  (Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.



Date:   August 14, 2003          By: /s/ Jeffrey F. Poore
                                 ---------------------------------------
                                 Jeffrey F. Poore
                                 President and Chief Executive Officer